1. Home
  2. MTDR vs BIO Comparison

MTDR vs BIO Comparison

Compare MTDR & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MTDR

Matador Resources Company

HOLD

Current Price

$60.48

Market Cap

7.3B

Sector

Energy

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$287.96

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTDR
BIO
Founded
2003
1952
Country
United States
United States
Employees
N/A
7450
Industry
Oil & Gas Production
Biotechnology: Laboratory Analytical Instruments
Sector
Energy
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
7.3B
7.1B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
MTDR
BIO
Price
$60.48
$287.96
Analyst Decision
Buy
Buy
Analyst Count
15
4
Target Price
$63.07
$339.75
AVG Volume (30 Days)
1.7M
248.1K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
2.46%
N/A
EPS Growth
N/A
N/A
EPS
6.09
N/A
Revenue
$3,696,277,000.00
N/A
Revenue This Year
$7.15
$2.74
Revenue Next Year
$7.63
$3.20
P/E Ratio
$10.05
$9.72
Revenue Growth
5.46
N/A
52 Week Low
$37.14
$211.43
52 Week High
$66.84
$343.12

Technical Indicators

Market Signals
Indicator
MTDR
BIO
Relative Strength Index (RSI) 53.83 51.55
Support Level $40.18 $256.85
Resistance Level $66.84 $289.61
Average True Range (ATR) 2.09 8.80
MACD -0.26 0.17
Stochastic Oscillator 61.05 40.58

Price Performance

Historical Comparison
MTDR
BIO

About MTDR Matador Resources Company

Matador Resources Co is an independent energy company engaged in the exploration, development, production, and acquisition of oil and natural gas resources. The majority of the company's assets are located in the United States, with an emphasis on oil and natural gas shale and other unconventional plays. Along with maintaining a portfolio of oil and natural gas properties, Matador works to identify and develop midstream opportunities that support and enhance its exploration and development business. The Company has two reportable business segments: exploration and production and midstream. The company generates majority of its revenue from the exploration and production segment.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: